Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- EGY +8.5%, WB +7.3%, DG +5.6%, PATH +5.2%, BUR +4.8%, DKS +4.4%, BBW +4.2%, WKC +2.2%, CGEM +1.4%
Other news:
- HEAR +27.2% (to acquire PDP for $118 mln and issues updated FY24 guidance)
- LAC +19.5% (Receives Conditional Commitment for $2.26 Billion ATVM Loan from the U.S. DOE for Construction of Thacker Pass; Provides a Thacker Pass Construction Plan Update)
- HOOD +12.3% (reports Feb operating data)
- IMRX +10% (topline results from the ongoing Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104)
- PI +4.9% (PI and NXPI settle patent disputes)
- GH +4.5% (ECLIPSE study data to be published in NEJM)
- MIRM +4.4% (receives FDA approval for LIVMARLI)
- BBW +4.2% (initiates dividend)
- TXG +1.8% (begins commercial shipments of chromium GEM-X)
- TLRY +1.8% (announces a groundbreaking achievement in the medical cannabis industry in Portugal)
- GOOD +1.3% (files $1.3 bln mixed shelf securities offering)
- PARA +1.1% (enters into transfer agreement with Reliance Industries; will sell entire 13.01% equity interest in Viacom 18 for $517 mln)
- NXPI +1% (PI and NXPI settle patent disputes)
- COIN +1% (prices offering of $1.1 bln of Convertible Senior Notes due 2030)